Inhibition of β-Catenin Signaling in the Skin Rescues Cutaneous Adipogenesis in Systemic Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial of C-82. [electronic resource]
Producer: 20171204Description: 2473-2483 p. digitalISSN:- 1523-1747
- Adipogenesis
- Adult
- Aged
- Aged, 80 and over
- Biomarkers -- metabolism
- Biopsy
- Cell Differentiation
- Cluster Analysis
- Double-Blind Method
- Epidermis -- metabolism
- Female
- Fibroblasts -- metabolism
- Gene Expression Profiling
- Gene Expression Regulation
- Heterocyclic Compounds, 2-Ring -- pharmacology
- Humans
- Male
- Middle Aged
- Oligonucleotide Array Sequence Analysis
- Piperazines -- pharmacology
- Scleroderma, Diffuse -- drug therapy
- Skin -- drug effects
- Time Factors
- Wnt Proteins -- metabolism
- Wnt Signaling Pathway
- beta Catenin -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.